Newsroom

SALT LAKE CITY--(BUSINESS WIRE)--FranklinCovey Hosts Exclusive Live Webinar with Bestselling Authors, Amy Edmondson, Stephen M.R. Covey and Liz Wiseman: Leadership in Uncertain Times...

NEPTUNE CITY, N.J.--(BUSINESS WIRE)--Nylabone, an iconic brand in the Central Garden & Pet portfolio (NASDAQ: CENT) (NASDAQ: CENTA), is bringing even more tail-wagging joy to treat time with the launch of Nubz® Flavor Bursts chew treats – a flavorful addition to its popular Nubz® dog treat line, just in time for summer snacking. Made with real cheddar cheese and irresistible bacon flavor, these natural chew treats are crafted using innovative technology that encapsulates savory flavor burst...

COPENHAGEN, Denmark--(BUSINESS WIRE)--Genmab A/S (Nasdaq: GMAB) today announced new results from the Phase 1b/2 EPCORE® NHL-2 trial Arm 10 (NCT04663347), evaluating epcoritamab, a T-cell engaging bispecific antibody administered subcutaneously, in combination with rituximab, ifosfamide, carboplatin, and etoposide (R-ICE) in adult patients with relapsed/refractory diffuse large B-cell lymphoma (R/R DLBCL) who are eligible for autologous stem cell transplantation (ASCT). Results demonstrated an o...

TOKYO--(BUSINESS WIRE)--ZAIKO will begin ticket sales on Sunday, June 15, 2025, at 6:00 PM JST for “BACK TO THE MEMORIES PART5,” starring FANTASTIC 6 -- a special unit of six members from LDH JAPAN’s FANTASTICS from EXILE TRIBE: Natsuki Sawamoto, Reiya Seguchi, Natsuki Hori, Keito Kimura, Yusei Yagi, and Sota Nakajima. [Event Details] BACK TO THE MEMORIES PART5 - Osaka Performance Start Times: Matinee: Saturday, June 21 at 12:00 PM Evening Show: Saturday, June 21 at 5:00 PM Ticket Purchase URL:...

東京--(BUSINESS WIRE)--(美國商業資訊)-- ZAIKO 將於 2025 年 6 月 15 日（星期日）日本時間下午 6 點，開始販售《BACK TO THE MEMORIES PART5》的門票。本次演出由 LDH JAPAN 所屬 FANTASTICS from EXILE TRIBE 中的 6 位成員組成的特別單元「FANTASTIC 6」主演，成員包括：澤本夏輝、瀬口黎弥、堀夏喜、木村慧人、八木勇征、中島颯太。 【活動資訊】 BACK TO THE MEMORIES PART5 – 大阪公演 演出時間： 日場：2025 年 6 月 21 日（星期六）中午 12:00 晚場：2025 年 6 月 21 日（星期六）下午 5:00 門票購買網址：https://fantastage-borderless.zaiko.io/?atprs ※門票可於大多數國家和地區購買及觀看，部分地區除外。 ※本次直播僅限海外觀眾觀看。...

VENLO, Netherlands & WILMINGTON, Del.--(BUSINESS WIRE)--QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) and Incyte (Nasdaq: INCY) today announced a new global collaboration to develop a novel diagnostic panel to support Incyte’s extensive portfolio of investigational therapies for patients with myeloproliferative neoplasms (MPNs), a group of rare blood cancers, including Incyte’s monoclonal antibody INCA033989, targeting mutant calreticulin (mutCALR), which is being developed in myelofi...

WILMINGTON, Del.--(BUSINESS WIRE)--Positive Late-Breaking Data for Incyte’s First-in-Class mutCALR-targeted therapy INCA033989 in Essential Thrombocythemia Presented at EHA2025...

BAODING, China--(BUSINESS WIRE)--While new energy vehicles continue to gain momentum worldwide, efficient diesel power remains a compelling choice—especially in challenging off-road environments where torque, range, and reliability are critical. GWM is advancing diesel technology with a focus on refinement, performance, and real-world usability. At the recent GWM Thailand Diesel Day event, the brand demonstrated how modern diesel can deliver a clean, quiet, and highly capable driving experience...

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, today provided a safety update regarding ELEVIDYS (delandistrogene moxeparvovec-rokl), the only approved gene therapy for patients with Duchenne muscular dystrophy, and steps the Company is taking to strengthen the safety profile in non-ambulatory patients. These steps follow a second reported case of acute liver failure (ALF) resulting in death. The cases of...

TÓQUIO--(BUSINESS WIRE)--A Kao Corporation (TÓQUIO: 4452) publicou o Kao Integrated Report 2025 (Relatório Integrado Kao de 2025) em seu site, oferecendo aos acionistas, investidores e todas as partes interessadas uma visão geral abrangente das iniciativas e da direção estratégica da empresa. Kao Integrated Report 2025 Para alcançar seu Plano de Médio Prazo “K27”, a Kao pretende se tornar uma presença única e indispensável para alguém no mundo e está avançando em sua estratégia Global Sharp Top...